Five-year risk of recurrence following treatment of CIN2, CIN3, or AIS: performance of HPV and Pap cotesting in post-treatment management

OBJECTIVE: After excisional treatment, CIN2+ can recur. It is not clear how many negative post-treatment Pap or cotest results are needed to assure adequate safety against CIN2+, prior to return to extended retesting intervals. METHODS: We observed 5-year risks of CIN2+, and outcomes for 3 follow-up...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Katki, Hormuzd A., Schiffman, Mark, Castle, Philip E., Fetterman, Barbara, Poitras, Nancy E., Lorey, Thomas, Cheung, Li C., Raine-Bennett, Tina, Gage, Julia C., Kinney, Walter K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3616418/
https://ncbi.nlm.nih.gov/pubmed/23519309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/LGT.0b013e31828543c5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados